The cost of newly diagnosed breast cancer in Lithuania, 2011

Medicina
Rugile IvanauskieneZilvinas Padaiga

Abstract

Although the cost of treating women with breast cancer (BC) is an important component for cost saving and effectiveness in relation to the benefits of BC treatment interventions, there is limited information on the direct cost reported for BC in Lithuania. Therefore the aim of this study was to evaluate annual direct medical cost for newly diagnosed BC in Lithuania in the year 2011. The retrospective incidence-based top-down direct cost analysis was used. From January 1 to December 31, 2011 incident cases of BC (N=1142) registered by the National Health Insurance Fund, the stage determined by Lithuanian Cancer Registry were included in the study. The total average direct cost of BC amounted per patient was 2580 (95% CI 2444-2752)EUR in 2011. The main cost driver per BC patients was the inpatient hospital stay, respectively 1655 (95% CI 1478-2334)EUR. The average outpatient cost for one BC patient was 564 (95% CI 547-898)EUR. The dominant proportion of inpatient expenditures was assigned to BC surgery and chemotherapy treatment. The BC direct medical cost increased according to the diagnosed stage of diseases from 2409 (95% CI 2196-2621)EUR in stage 1 to 3688 (95% CI 2703-4672)EUR in stage 4. The direct medical cost was inversel...Continue Reading

References

Mar 6, 2004·Breast Cancer Research and Treatment·S RaoD Gilden
Jan 12, 2007·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Mathias LidgrenBengt Jönsson
May 12, 2007·International Journal of Technology Assessment in Health Care·Mathias LidgrenClas Rehnberg
Apr 29, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L DahlbergH Lindman
Mar 23, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Steven BroekxSteven Simoens
Jan 14, 2011·Journal of the National Cancer Institute·Angela B MariottoMartin L Brown
Apr 5, 2011·Current Opinion in Ophthalmology·Melissa M BrownP Alexander Lieske
Aug 7, 2013·Hematology/oncology Clinics of North America·Michael J Hassett, Elena B Elkin
Oct 18, 2013·The Lancet Oncology·Gary H Lyman
Oct 18, 2013·The Lancet Oncology·Ramon Luengo-FernandezRichard Sullivan

❮ Previous
Next ❯

Citations

Jul 4, 2017·Asia-Pacific Journal of Clinical Oncology·Xian-Zhen LiaoUNKNOWN Health Economic Evaluation Working Group, Cancer Screening Program in Urban China (CanSPUC)
Oct 12, 2017·BMC Cancer·Błażej Łyszczarz, Ewelina Nojszewska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Steven BroekxSteven Simoens
Annals of Oncology : Official Journal of the European Society for Medical Oncology
A BrunelloS Monfardini
© 2022 Meta ULC. All rights reserved